Detroit research team to expand imaging technology to guide cancer treatment

June 13, 2017

A team of Wayne State University and Barbara Ann Karmanos Cancer Institute researchers recently received funding from the National Cancer Institute of the National Institutes of Health to expand the use of Positron Emission Tomography (PET) in cancer therapy.

PET imaging is a common tool used in cancer diagnosis. Wei-Zen Wei, Ph.D., the Herrick Chair of Cancer Research at the Barbara Ann Karmanos Cancer Institute and professor of oncology and immunology and microbiology in the School of Medicine at Wayne State University, along with Nerissa Viola-Villegas, Ph.D., assistant professor of oncology in Wayne State University's School of Medicine and the Karmanos Cancer Institute, plan to expand the use of this technology with the help of the two-year, $368,445 grant, "Directing Cancer Immunotherapy and Real-Time ImmunoPET."

According to Wei, current immune-based therapies are effective in some patients with existing anti-tumor immunity, but most are not responsive, therefore revealing the need for immune priming and non-invasive monitoring strategies.

Wei and Viola-Villegas will expand PET imaging technology for cancer immunotherapy by imaging —the specialized that can trigger tumor-fighting immunity. Cancer treatment that brings more dendritic cells into a tumor is more likely to cure cancer.

"Assessing if cancer treatments are effective is often invasive and difficult," said Joseph Dunbar, Ph.D., director of special operations in the Office of the Vice President for Research at Wayne State. "Drs. Wei and Viola-Villegas' method of using PET imaging will be a less invasive, strong indicator of whether cancer treatments are effective."

The research team will develop new imaging probes to detect dendritic cells in the tumor, which will measure the dendritic cells and predict treatment outcome. Their findings may help develop immunoPET, which, in turn, will guide patient treatment in a non-invasive way.

Explore further: PET radiotracer design for monitoring targeted immunotherapy

Related Stories

PET radiotracer design for monitoring targeted immunotherapy

April 7, 2017
In an article published in the April issue of The Journal of Nuclear Medicine, researchers at Stanford University in California provide a template for assessing new positron emission tomography (PET) radiotracers that can ...

Identifying a novel target for cancer immunotherapy

April 12, 2017
Targeting a molecule called B7-H4—which blocks T-cells from destroying tumor cells—could lead to the development of new therapies that boost the immune system's ability to fight cancer, according to a review published ...

Patients' immune system may influence effectiveness of cancer immunotherapy

April 2, 2017
Higher or lower levels of certain immune cells in cancer patients may be associated with how well they respond to immunotherapy, according to preliminary results of a study conducted by researchers at the University of Pittsburgh ...

Vaccine shows promising results for early-stage breast cancer patients

January 3, 2017
Deregulation and inhibition of the immune system contributes to cancer development. Many therapeutic strategies aim to re-stimulate the immune system to recognize cancer cells and target them for destruction. Researchers ...

Researchers find new driver of an aggressive form of brain cancer

November 15, 2016
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age. The discovery can help researchers ...

Research explains limits of cancer immunotherapy drugs

October 26, 2015
Immunotherapy treatments have proven wildly successful in treating some patients with cancer. But despite this success, the majority of patients do not respond to the treatments.

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.